What happens when a clinical trial ends?

The information gathered from all the patients who have participated is studied and discussed in scientific meetings, published as an article in medical journals and becomes accessible so that other physicians can help their patients by knowing how the studied drug has worked.

Individual information is never published about the people who have participated in the trial, such as the name or contact address.

A clinical trial finishes when it reaches Phase 3 and it has obtained positive results that allow the authorization of the drug.